Targeted discovery and validation of plasma biomarkers of Parkinsons disease

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4535-4545

  Pan, Catherine ^a,b   Zhou, Yong ^c   Dator, Romel ^a   Ginghina, Carmen ^a   Zhao, Yanchun ^a   Movius, James ^a   Peskind, Elaine ^a,d   Zabetian, Cyrus P ^a,d   Quinn, Joseph ^e   Galasko, Douglas ^f   Stewart, Tessandra ^a   Shi, Min ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Inarian Neurodiagnostics   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Parkinsons disease; peripheral biomarkers; selected reaction monitoring; targeted mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; GLYCOPEPTIDE; GLYCOPROTEIN; PROTEIN TAG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION STUDY; AREA UNDER THE CURVE; BLOOD; COHORT ANALYSIS; GENETICS; METABOLISM; PATHOLOGY;

AREA UNDER CURVE; BIOMARKERS; COHORT STUDIES; DISEASE PROGRESSION; GLYCOPEPTIDES; GLYCOPROTEINS; HUMANS; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY;

EID: 84908873792     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500421v     Document Type: Article

References (58)

1. Lang, A. E.; Lozano, A. M. Parkinsons disease. First of two parts N. Engl. J. Med. 1998, 339 (15) 1044-1053
2. Thomas, B.; Beal, M. F. Parkinsons disease Hum. Mol. Genet. 2007, 16 (Spec No. 2) R183-194
3. Shulman, J. M.; De Jager, P. L.; Feany, M. B. Parkinsons disease: genetics and pathogenesis Annu. Rev. Pathol. 2011, 6, 193-222
4. Jankovic, J. Parkinsons disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatry 2008, 79 (4) 368-376
5. Sollinger, A. B.; Goldstein, F. C.; Lah, J. J.; Levey, A. I.; Factor, S. A. Mild cognitive impairment in Parkinsons disease: subtypes and motor characteristics Parkinsonism Relat. Disord. 2010, 16 (3) 177-180
6. Reichmann, H.; Schneider, C.; Lohle, M. Non-motor features of Parkinsons disease: depression and dementia Parkinsonism Relat. Disord. 2009, 15 (Suppl 3) S87-S92
7. Moore, D. J.; West, A. B.; Dawson, V. L.; Dawson, T. M. Molecular pathophysiology of Parkinsons disease Annu. Rev. Neurosci. 2005, 28, 57-87
8. Schapira, A. H. Recent developments in biomarkers in Parkinson disease Curr. Opin. Neurol. 2013, 26 (4) 395-400
9. Shi, M.; Bradner, J.; Hancock, A. M.; Chung, K. A.; Quinn, J. F.; Peskind, E. R.; Galasko, D.; Jankovic, J.; Zabetian, C. P.; Kim, H. M.; Leverenz, J. B.; Montine, T. J.; Ginghina, C.; Kang, U. J.; Cain, K. C.; Wang, Y.; Aasly, J.; Goldstein, D. S.; Zhang, J. Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression Ann. Neurol. 2011, 69 (3) 570-580
10. Mollenhauer, B.; Locascio, J. J.; Schulz-Schaeffer, W.; Sixel-Döring, F.; Trenkwalder, C.; Schlossmacher, M. G. alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study Lancet Neurol. 2011, 10 (3) 230-240
11. Zhang, J.; Goodlett, D. R.; Montine, T. J. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases J. Alzheimers Dis. 2005, 8 (4) 377-386
12. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Sun, Z.; Watts, J. D.; Yamamoto, T.; Shteynberg, D.; Harris, M. M.; Moritz, R. L. State of the Human Proteome in 2013 as Viewed through PeptideAtlas: Comparing the Kidney, Urine, and Plasma Proteomes for the Biology-and Disease-Driven Human Proteome Project J. Proteome Res. 2014, 13 (1) 60-75
13. Breen, D. P.; Michell, A. W.; Barker, R. A. Parkinsons disease-the continuing search for biomarkers Clin. Chem. Lab. Med. 2011, 49 (3) 393-401
14. Haab, B. B.; Paulovich, A. G.; Anderson, N. L.; Clark, A. M.; Downing, G. J.; Hermjakob, H.; Labaer, J.; Uhlen, M. A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report Mol. Cell. Proteomics 2006, 5 (10) 1996-2007
15. Parker, C. E.; Pearson, T. W.; Anderson, N. L.; Borchers, C. H. Mass-spectrometry-based clinical proteomics-a review and prospective Analyst 2010, 135 (8) 1830-1838
16. Chen-Plotkin, A. S.; Hu, W. T.; Siderowf, A.; Weintraub, D.; Goldmann Gross, R.; Hurtig, H. I.; Xie, S. X.; Arnold, S. E.; Grossman, M.; Clark, C. M.; Shaw, L. M.; McCluskey, L.; Elman, L.; Van Deerlin, V. M.; Lee, V. M.; Soares, H.; Trojanowski, J. Q. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease Ann. Neurol. 2011, 69 (4) 655-663
17. Pellecchia, M. T.; Santangelo, G.; Picillo, M.; Pivonello, R.; Longo, K.; Pivonello, C.; Vitale, C.; Amboni, M.; De Rosa, A.; Moccia, M.; Erro, R.; De Michele, G.; Santoro, L.; Colao, A.; Barone, P. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinsons disease patients J. Neurol. 2013, 260 (2) 438-444
18. Qiang, J. K.; Wong, Y. C.; Siderowf, A.; Hurtig, H. I.; Xie, S. X.; Lee, V. M.; Trojanowski, J. Q.; Yearout, D.; J, B. L.; Montine, T. J.; Stern, M.; Mendick, S.; Jennings, D.; Zabetian, C.; Marek, K.; Chen-Plotkin, A. S. Plasma apolipoprotein A1 as a biomarker for Parkinson disease Ann. Neurol. 2013, 74 (1) 119-127
19. Derkinderen, P.; Rouaud, T.; Lebouvier, T.; Bruley des Varannes, S.; Neunlist, M.; De Giorgio, R. Parkinson disease: the enteric nervous system spills its guts Neurology 2011, 77 (19) 1761-1767
20. Wang, N.; Gibbons, C. H.; Lafo, J.; Freeman, R. alpha-Synuclein in cutaneous autonomic nerves Neurology 2013, 81 (18) 1604-1610
21. Hwang, H.; Zhang, J.; Chung, K. A.; Leverenz, J. B.; Zabetian, C. P.; Peskind, E. R.; Jankovic, J.; Su, Z.; Hancock, A. M.; Pan, C.; Montine, T. J.; Pan, S.; Nutt, J.; Albin, R.; Gearing, M.; Beyer, R. P.; Shi, M.; Zhang, J. Glycoproteomics in neurodegenerative diseases Mass Spectrom. Rev. 2010, 29 (1) 79-125
22. Li, X. J.; Hayward, C.; Fong, P. Y.; Dominguez, M.; Hunsucker, S. W.; Lee, L. W.; McLean, M.; Law, S.; Butler, H.; Schirm, M.; Gingras, O.; Lamontagne, J.; Allard, R.; Chelsky, D.; Price, N. D.; Lam, S.; Massion, P. P.; Pass, H.; Rom, W. N.; Vachani, A.; Fang, K. C.; Hood, L.; Kearney, P. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules Sci. Transl. Med. 2013, 5 (207) 207ra142
23. Ossola, R.; Schiess, R.; Picotti, P.; Rinner, O.; Reiter, L.; Aebersold, R. Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites Methods Mol. Biol. 2011, 728, 179-194
24. Selevsek, N.; Matondo, M.; Sanchez Carbayo, M.; Aebersold, R.; Domon, B. Systematic quantification of peptides/proteins in urine using selected reaction monitoring Proteomics 2011, 11 (6) 1135-1147
25. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-641
26. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-588
27. Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21 (6) 660-666
28. Sihlbom, C.; Davidsson, P.; Sjogren, M.; Wahlund, L. O.; Nilsson, C. L. Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimers disease patients and healthy individuals Neurochem. Res. 2008, 33 (7) 1332-1340
29. Gibb, W. R.; Lees, A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease J. Neurol. Neurosurg. Psychiatry 1988, 51 (6) 745-752
30. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E. M. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease Neurology 1984, 34 (7) 939-944
31. Shi, M.; Zabetian, C. P.; Hancock, A. M.; Ginghina, C.; Hong, Z.; Yearout, D.; Chung, K. A.; Quinn, J. F.; Peskind, E. R.; Galasko, D.; Jankovic, J.; Leverenz, J. B.; Zhang, J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinsons disease Neurosci. Lett. 2010, 480 (1) 78-82
32. Zhang, H.; Loriaux, P.; Eng, J.; Campbell, D.; Keller, A.; Moss, P.; Bonneau, R.; Zhang, N.; Zhou, Y.; Wollscheid, B.; Cooke, K.; Yi, E. C.; Lee, H.; Peskind, E. R.; Zhang, J.; Smith, R. D.; Aebersold, R. UniPep-a database for human N-linked glycosites: a resource for biomarker discovery Genome Biol. 2006, 7 (8) R73
33. Tian, Y.; Zhou, Y.; Elliott, S.; Aebersold, R.; Zhang, H. Solid-phase extraction of N-linked glycopeptides Nat. Protoc. 2007, 2 (2) 334-339
34. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-968
35. Lai, Z. W.; Nice, E. C.; Schilling, O. Glycocapture-based proteomics for secretome analysis Proteomics 2013, 13 (3-4) 512-525
36. Wollscheid, B.; Bausch-Fluck, D.; Henderson, C.; OBrien, R.; Bibel, M.; Schiess, R.; Aebersold, R.; Watts, J. D. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins Nat. Biotechnol. 2009, 27 (4) 378-386
37. Qin, S.; Zhou, Y.; Lok, A. S.; Tsodikov, A.; Yan, X.; Gray, L.; Yuan, M.; Moritz, R. L.; Galas, D.; Omenn, G. S.; Hood, L. SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients Proteomics 2012, 12 (8) 1244-1252
38. Weissmann, C. The state of the prion Nat. Rev. Microbiol. 2004, 2 (11) 861-871
39. Zomosa-Signoret, V.; Arnaud, J. D.; Fontes, P.; Alvarez-Martinez, M. T.; Liautard, J. P. Physiological role of the cellular prion protein Vet. Res. 2008, 39 (4) 9
40. Banks, W. A.; Robinson, S. M.; Diaz-Espinoza, R.; Urayama, A.; Soto, C. Transport of prion protein across the blood-brain barrier Exp. Neurol. 2009, 218 (1) 162-167
41. Head, M. W.; Ironside, J. W. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain Neuropathol. Appl. Neurobiol. 2012, 38 (4) 296-310
42. Forloni, G.; Balducci, C. beta-amyloid oligomers and prion protein: Fatal attraction? Prion 2011, 5 (1) 10-15
43. Um, J. W.; Nygaard, H. B.; Heiss, J. K.; Kostylev, M. A.; Stagi, M.; Vortmeyer, A.; Wisniewski, T.; Gunther, E. C.; Strittmatter, S. M. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons Nat. Neurosci. 2012, 15 (9) 1227-1235
44. Wielgat, P.; Braszko, J. J. Significance of the cell adhesion molecules and sialic acid in neurodegeneration Adv. Med. Sci. 2012, 57 (1) 23-30
45. Deguchi, Y.; Okutsu, H.; Okura, T.; Yamada, S.; Kimura, R.; Yuge, T.; Furukawa, A.; Morimoto, K.; Tachikawa, M.; Ohtsuki, S.; Hosoya, K.; Terasaki, T. Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan J. Neurochem. 2002, 83 (2) 381-389
46. Desai, B. S.; Monahan, A. J.; Carvey, P. M.; Hendey, B. Blood-brain barrier pathology in Alzheimers and Parkinsons disease: implications for drug therapy Cell Transplant. 2007, 16 (3) 285-299
47. Loov, C.; Hillered, L.; Ebendal, T.; Erlandsson, A. Engulfing astrocytes protect neurons from contact-induced apoptosis following injury PLoS One 2012, 7 (3) e33090
48. Hong, Z.; Shi, M.; Chung, K. A.; Quinn, J. F.; Peskind, E. R.; Galasko, D.; Jankovic, J.; Zabetian, C. P.; Leverenz, J. B.; Baird, G.; Montine, T. J.; Hancock, A. M.; Hwang, H.; Pan, C.; Bradner, J.; Kang, U. J.; Jensen, P. H.; Zhang, J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinsons disease Brain 2010, 133 (Pt 3) 713-726
49. Fan, J.; Hu, Z.; Zeng, L.; Lu, W.; Tang, X.; Zhang, J.; Li, T. Golgi apparatus and neurodegenerative diseases Int. J. Dev. Neurosci. 2008, 26 (6) 523-534
50. McGhee, D. J.; Royle, P. L.; Thompson, P. A.; Wright, D. E.; Zajicek, J. P.; Counsell, C. E. A systematic review of biomarkers for disease progression in Parkinsons disease BMC Neurol. 2013, 13, 35
51. Lawson, C.; Wolf, S. ICAM-1 signaling in endothelial cells Pharmacol. Rep. 2009, 61 (1) 22-32
52. Mannam, V. K.; Lewis, R. E.; Cruse, J. M. The fate of renal allografts hinges on responses of the microvascular endothelium Exp. Mol. Pathol. 2013, 94 (2) 398-411
53. McNally, R. S.; Davis, B. K.; Clements, C. M.; Accavitti-Loper, M. A.; Mak, T. W.; Ting, J. P. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB J. Biol. Chem. 2011, 286 (6) 4098-4106
54. Klegeris, A.; Giasson, B. I.; Zhang, H.; Maguire, J.; Pelech, S.; McGeer, P. L. Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells FASEB J. 2006, 20 (12) 2000-2008
55. Deleidi, M.; Gasser, T. The role of inflammation in sporadic and familial Parkinsons disease Cell. Mol. Life Sci. 2013, 70 (22) 4259-4273
56. Taylor, J. M.; Main, B. S.; Crack, P. J. Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinsons disease Neurochem. Int. 2013, 62 (5) 803-819
57. Lin, X.; Cook, T. J.; Zabetian, C. P.; Leverenz, J. B.; Peskind, E. R.; Hu, S. C.; Cain, K. C.; Pan, C.; Edgar, J. S.; Goodlett, D. R.; Racette, B. A.; Checkoway, H.; Montine, T. J.; Shi, M.; Zhang, J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease Sci. Rep. 2012, 2, 954
58. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Campbell, D. S.; Sun, Z.; Bletz, J. A.; Mallick, P.; Katz, J. E.; Malmstrom, J.; Ossola, R.; Watts, J. D.; Lin, B.; Zhang, H.; Moritz, R. L.; Aebersold, R. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol. Cell. Proteomics 2011, 10 (9) M110 006353